Industry and partners
- Merck Serono: in pursuit of "best pharma" status
- Crucell multiplies its clinical trials
- Rhenovia: simulating nerve impulse
The stock market, fundraising and milestones
- Novagali turns to Euronext once more
France
- Biotechs: the age of reason